SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-200433
Filing Date
2022-07-25
Accepted
2022-07-25 07:15:12
Documents
18
Period of Report
2022-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d368627d8k.htm   iXBRL 8-K 57807
2 EX-2.1 d368627dex21.htm EX-2.1 599753
3 EX-10.1 d368627dex101.htm EX-10.1 56020
4 EX-10.2 d368627dex102.htm EX-10.2 60777
5 EX-10.3 d368627dex103.htm EX-10.3 70932
6 EX-99.1 d368627dex991.htm EX-99.1 24212
  Complete submission text file 0001193125-22-200433.txt   1251391

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA dna-20220724.xsd EX-101.SCH 3929
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20220724_def.xml EX-101.DEF 14072
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20220724_lab.xml EX-101.LAB 23328
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20220724_pre.xml EX-101.PRE 15098
12 EXTRACTED XBRL INSTANCE DOCUMENT d368627d8k_htm.xml XML 5415
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 221101008
SIC: 2836 Biological Products, (No Diagnostic Substances)